{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T17:20:49Z","timestamp":1783358449858,"version":"3.54.6"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"S2","license":[{"start":{"date-parts":[[2021,8,21]],"date-time":"2021-08-21T00:00:00Z","timestamp":1629504000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2021,8,21]],"date-time":"2021-08-21T00:00:00Z","timestamp":1629504000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100011725","name":"Servier","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1007\/s12325-021-01861-0","type":"journal-article","created":{"date-parts":[[2021,8,21]],"date-time":"2021-08-21T09:02:55Z","timestamp":1629536575000},"page":"61-68","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Revisiting Treatment Options for Depressed Patients with Generalised Anxiety Disorder"],"prefix":"10.1007","volume":"38","author":[{"given":"Guy M.","family":"Goodwin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,21]]},"reference":[{"key":"1861_CR1","doi-asserted-by":"crossref","unstructured":"GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1204\u201322.","DOI":"10.1016\/S0140-6736(20)30925-9"},{"issue":"6","key":"1861_CR2","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1002\/da.22991","volume":"37","author":"G Morneau-Vaillancourt","year":"2020","unstructured":"Morneau-Vaillancourt G, Coleman JRI, Purves KL, et al. The genetic and environmental hierarchical structure of anxiety and depression in the UK Biobank. Depress Anxiety. 2020;37(6):512\u201320.","journal-title":"Depress Anxiety"},{"issue":"3","key":"1861_CR3","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1002\/da.23113","volume":"38","author":"S Saha","year":"2020","unstructured":"Saha S, Lim CCW, Cannon DL, et al. Co-morbidity between mood and anxiety disorders: a systematic review and meta-analysis. Depress Anxiety. 2020;38(3):286\u2013306.","journal-title":"Depress Anxiety"},{"issue":"1","key":"1861_CR4","doi-asserted-by":"publisher","first-page":"40511","DOI":"10.1038\/srep40511","volume":"7","author":"Y Zhou","year":"2017","unstructured":"Zhou Y, Cao Z, Yang M, et al. Comorbid generalized anxiety disorder and its association with quality of life in patients with major depressive disorder. Sci Rep. 2017;7(1):40511.","journal-title":"Sci Rep"},{"issue":"3","key":"1861_CR5","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1177\/2040622315627805","volume":"7","author":"RS McIntyre","year":"2016","unstructured":"McIntyre RS, Woldeyohannes HO, Soczynska JK, et al. The prevalence and clinical characteristics associated with diagnostic and statistical manual version-5-defined anxious distress specifier in adults with major depressive disorder: results from the international mood disorders collaborative project. Ther Adv Chronic Dis. 2016;7(3):153\u20139.","journal-title":"Ther Adv Chronic Dis"},{"issue":"1","key":"1861_CR6","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1097\/YCO.0000000000000376","volume":"31","author":"R Gaspersz","year":"2018","unstructured":"Gaspersz R, Nawijn L, Lamers F, Penninx B. Patients with anxious depression: overview of prevalence, pathophysiology and impact on course and treatment outcome. Curr Opin Psychiatry. 2018;31(1):17\u201325.","journal-title":"Curr Opin Psychiatry"},{"key":"1861_CR7","doi-asserted-by":"crossref","unstructured":"Kendler KS. Major depression and generalised anxiety disorder. Same genes, (partly) different environments--revisited. Br J Psychiatry. 1996;168(Suppl 30):68\u201375.","DOI":"10.1192\/S0007125000298437"},{"key":"1861_CR8","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"2013","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington: American Psychiatric; 2013.","edition":"5"},{"key":"1861_CR9","unstructured":"World Health Organization. ICD-10 Version: 2019 https:\/\/icd.who.int\/browse10\/2019\/en. Accessed 26 January 2021."},{"key":"1861_CR10","unstructured":"World Health Organization. ICD-11 for mortality and morbidity statistics (version: 09\/2020). https:\/\/icd.who.int\/browse11\/l-m\/en. Accessed 26 January 2021."},{"issue":"8","key":"1861_CR11","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s00406-016-0684-7","volume":"266","author":"HJ M\u00f6ller","year":"2016","unstructured":"M\u00f6ller HJ, Bandelow B, Volz HP, Barnikol UB, Seifritz E, Kasper S. The relevance of \u201cmixed anxiety and depression\u201d as a diagnostic category in clinical practice. Eur Arch Psychiatry Clin Neurosci. 2016;266(8):725\u201336.","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"1861_CR12","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jpsychires.2019.08.014","volume":"118","author":"TR Chen","year":"2019","unstructured":"Chen TR, Huang HC, Hsu JH, Ouyang WC, Lin KC. Pharmacological and psychological interventions for generalized anxiety disorder in adults: a network meta-analysis. J Psychiatr Res. 2019;118:73\u201383.","journal-title":"J Psychiatr Res"},{"issue":"10128","key":"1861_CR13","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1016\/S0140-6736(17)32802-7","volume":"391","author":"A Cipriani","year":"2018","unstructured":"Cipriani A, Furukawa TA, Salanti G, et al. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet. 2018;391(10128):1357\u201366.","journal-title":"Lancet"},{"issue":"5","key":"1861_CR14","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1177\/0269881115581093","volume":"29","author":"A Cleare","year":"2015","unstructured":"Cleare A, Pariante CM, Young AH, et al. Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2008 British Association for Psychopharmacology guidelines. J Psychopharmacol. 2015;29(5):459\u2013525.","journal-title":"J Psychopharmacol"},{"issue":"9","key":"1861_CR15","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1177\/0706743716659417","volume":"61","author":"SH Kennedy","year":"2016","unstructured":"Kennedy SH, Lam RW, McIntyre RS, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 3. Pharmacological treatments. Can J Psychiatry. 2016;61(9):540\u201360.","journal-title":"Can J Psychiatry"},{"issue":"9","key":"1861_CR16","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1177\/0706743716659418","volume":"61","author":"SV Parikh","year":"2016","unstructured":"Parikh SV, Quilty LC, Ravitz P, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 2. Psychological treatments. Can J Psychiatry. 2016;61(9):524\u201339.","journal-title":"Can J Psychiatry"},{"key":"1861_CR17","doi-asserted-by":"crossref","unstructured":"Ogawa Y, Takeshima N, Hayasaka Y, et al. Antidepressants plus benzodiazepines for adults with major depression. Cochrane Database Syst Rev. 2019;6:CD001026.","DOI":"10.1002\/14651858.CD001026.pub2"},{"key":"1861_CR18","doi-asserted-by":"publisher","unstructured":"Browning M, Bilderbeck AC, Dias R, et al. The clinical effectiveness of using a predictive algorithm to guide antidepressant treatment in primary care (PReDicT): an open-label, randomised controlled trial. Neuropsychopharmacology. 2021. https:\/\/doi.org\/10.1038\/s41386-021-00981-z.","DOI":"10.1038\/s41386-021-00981-z"},{"issue":"11","key":"1861_CR19","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/S2215-0366(19)30366-9","volume":"6","author":"G Lewis","year":"2019","unstructured":"Lewis G, Duffy L, Ades A, et al. The clinical effectiveness of sertraline in primary care and the role of depression severity and duration (PANDA): a pragmatic, double-blind, placebo-controlled randomised trial. Lancet Psychiatry. 2019;6(11):903\u201314.","journal-title":"Lancet Psychiatry"},{"key":"1861_CR20","doi-asserted-by":"crossref","unstructured":"Garakani A, Murrough JW, Freire RC, et al. Pharmacotherapy of anxiety disorders: current and emerging treatment options. Front Psychiatry. 2020;11:595584.","DOI":"10.3389\/fpsyt.2020.595584"},{"key":"1861_CR21","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.jad.2016.07.015","volume":"206","author":"DS Baldwin","year":"2016","unstructured":"Baldwin DS, Florea I, Jacobsen PL, Zhong W, Nomikos GG. A meta-analysis of the efficacy of vortioxetine in patients with major depressive disorder (MDD) and high levels of anxiety symptoms. J Affect Disord. 2016;206:140\u201350.","journal-title":"J Affect Disord"},{"issue":"8","key":"1861_CR22","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.4088\/JCP.v69n0812","volume":"69","author":"GI Papakostas","year":"2008","unstructured":"Papakostas GI, Stahl SM, Krishen A, et al. Efficacy of bupropion and the selective serotonin reuptake inhibitors in the treatment of major depressive disorder with high levels of anxiety (anxious depression): a pooled analysis of 10 studies. J Clin Psychiatry. 2008;69(8):1287\u201392.","journal-title":"J Clin Psychiatry"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-021-01861-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-021-01861-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-021-01861-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,13]],"date-time":"2021-09-13T04:28:02Z","timestamp":1631507282000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-021-01861-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,21]]},"references-count":22,"journal-issue":{"issue":"S2","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["1861"],"URL":"https:\/\/doi.org\/10.1007\/s12325-021-01861-0","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,21]]},"assertion":[{"value":"12 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}